Alterations in TP53, KRAS, ARID1A, and APC in gastric cancer patients and alterations in KRAS, TP53, SMAD4, CDKN2A, and CDKN2B in pancreatic cancer patients were observed (Table 2). Here, SMAD4 is linked to pancreatic neoplasm.